ENOX2 and melanoma: In recent years, efforts to target tNOX with RNA interference or conventional anticancer drugs have shown promising results in reducing cancer, not just in cell-based functional studies but also in animals inoculated with cancer cells of colon cancer and melanoma (Liu et al., 2012; Islam et al., 2021).